SEARCH

SEARCH BY CITATION

References

  • 1
    Adam R, Karam V, Delvart V, Höckerstedt K. Ten-year evolution of liver transplantation in Europe-Report of the European Liver Transplant Registry (ELTR). In: KöckerlingF, SchwartzSI, eds. Liver Surgery. Operative Techniques and Avoidance of Complications. Heidelberg: Barth JA, 2001;195203.
  • 2
    Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of the liver allograft. J Hepatol 2001; 34:762763.
  • 3
    Berenguer M, Rayon JM, Prieto M, Aguilera V, Nicolas D, Ortiz V, Carrasco D, et al. Are posttransplantation liver biopsies useful in the long term? Liver Transpl 2001; 7:790796.
  • 4
    Abbasoglu O, Levy ML, Brkic BB, Testa G, Jeyarajah R, Goldstein R, Husberg BS, et al. Ten years of liver transplantation. An evolving understanding of late graft loss. Transplantation 1997; 64:18011807.
  • 5
    Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995; 19:192206.
  • 6
    Slapak G, Saxena R, Portmann B, Gane E, Devlin J, Calne R, Williams R. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997; 25:195202.
  • 7
    Jain A, Mazariegos G, Kashyap R, Green M, Gronski C, Starzl TE, Fung J, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000; 27:617625.
  • 8
    Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, Abu-Elmagd K, et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single centre. Ann Surg 2000; 232:490500.
  • 9
    Böcker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203210.
  • 10
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334:815820.
  • 11
    Berenguer M, Wright TL. Hepatitis C and liver transplantation. Gut 1999; 45:159163.
  • 12
    Prieto M, Berenguer M, Rayon M, Cordoba J, Arguello L, Carrasco D, Garcia-Herola A, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 334:815820.
  • 13
    Berenguer M, Ferrel L, Watson J, Prieto M, Kim M, Rayon M, Cordoba J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32:673684.
  • 14
    Neil DAH, Hubscher SG. Histological changes during the evolution of chronic rejection of liver allografts. Hepatology 2002; 35:639651.
  • 15
    Demetris AJ, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, et al. Update of the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An international panel. Hepatology 2000; 31:792799.
  • 16
    The French METAVIR Cooperative Study Group. Interobserver and intraobserver variation in LB interpretation in patients with chronic hepatitis C. Hepatology 1994; 20:1520.
  • 17
    Sebagh M, Blakolmer K, Falissard B, Roche B, Emile JF, Bismuth H, Samuel D, et al. Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema. Hepatology 2002; 35:117125.
  • 18
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825832.
  • 19
    Benhamou Y, Bochet M, Di Charlotte F, Azria F, Coutellier A, Vidaud M, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. Hepatology 1999; 30:10541058.
  • 20
    Poynard T, Ratziu V, Benhamou Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis 2000; 20:4755.
  • 21
    Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34:730739.
  • 22
    Samuel D, Bismuth H, Mathieu D, Arulnaden JL, Reynès M, Benhamou JP, Bréchot C, et al. Passive immunoprophylaxis after liver transplantation in HbsAg-positive patients. Lancet 1999; 337:813815.
  • 23
    Blakolmer K, Jain A, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, et al. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000; 69:23302336.
  • 24
    Blakolmer K, Seaberg EC, Batts K, Ferrell L, Markin R, Wiesner R, Detre K, et al. Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema. Am J Surg Pathol 1999; 23:13281339.
  • 25
    Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, Loinaz C, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European concerted action on viral hepatitis (EUROHEP) group. Gastroenterology 1999; 117:619625.
  • 26
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Urdea M, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20:11371143.
  • 27
    Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002; 51:248252.
  • 28
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000; 6:553561.
  • 29
    Hunt J, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens. Liver Transpl 2001; 7:10561063.
  • 30
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28:823830.
  • 31
    Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21:3034.
  • 32
    Berenguer M, Prieto M, Rayon M, Martinez F, Carrasco D, Moya A, Orbis F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36:202210.
  • 33
    Vaillant GE. The natural history of alcoholism revisited. Boston, MA: Harvard University, 1995;119, 231, 297.